Zeposia 0.92 MG capsule 30S
Ended Awarded
- Contract number
- SPE2DR26FY9N0
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,870
Award facts
- Contract value 100% obligated
- $4,869.75 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $4,869.75 to AmerisourceBergen Drug Corp for the supply of Zeposia 0.92 mg capsules (30-count units) on November 5, 2025, with completion scheduled for November 28, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which is valued at $999,999,999.00 and extends through December 2026, serving as the primary vehicle for pharmaceutical and medical supply distribution to military healthcare systems globally.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive federal contract portfolio demonstrates its capability to deliver a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. This specific delivery order for Zeposia, a prescription immunosuppressant medication, exemplifies the type of specialty pharmaceutical commodities the contractor routinely supplies through its DLA contracts to support military medical operations.
Quick answers
Who was awarded contract SPE2DR26FY9N0?
SPE2DR26FY9N0 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 5, 2025.
How much is contract SPE2DR26FY9N0 worth?
The government has obligated $4,870 on SPE2DR26FY9N0.
Is contract SPE2DR26FY9N0 an order under another contract?
Yes. SPE2DR26FY9N0 is a delivery order under SPE2DR25D2018, an indefinite delivery contract.
Was contract SPE2DR26FY9N0 competed?
The extent of competition for SPE2DR26FY9N0 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award